Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy

Journal of Hepatology

Volumn 48, Issue 2, 2008, Pages 229-236

  Abraldes, Juan G ^a   Villanueva, Cándid ^b   Bañares, Rafael ^c   Aracil, Carles ^b   Catalina, Maria Vega ^c   García Pagán, Juan Carlos ^a   Bosch, Jaime ^a  

^a Hepat Hemodynamic Lab Liver U   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Endoscopy; Portal hypertension; Prognostic models

Indexed keywords

OCTREOTIDE; SOMATOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE; VARIX BLEEDING; VENOUS PRESSURE;

EID: 38049009057     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.10.008     Document Type: Article

References (36)

1. Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E.J., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-659
2. Carbonell N., Pauwels A., Serfaty L., Fourdan O., Levy V.G., and Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (2004) 652-659
3. Stokkeland K., Brandt L., Ekbom A., and Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. Hepatology 43 (2006) 500-505
4. D'Amico G., and de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
5. Moitinho E., Escorsell A., Bandi J.C., Salmeron J.M., Garcia-Pagan J.C., Rodes J., et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117 (1999) 626-631
6. Moitinho E., Planas R., Bañares R., Albillos A., Ruiz-del-Arbol L., Galvez C., et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol 35 (2001) 712-718
7. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
8. Villanueva C., Ortiz J., Minana J., Soriano G., Sabat M., Boadas J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121 (2001) 110-117
9. Monescillo A., Martinez-Lagares F., Ruiz-del-Arbol L., Sierra A., Guevara C., Jimenez E., et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40 (2004) 793-801
10. Bosch J., Thabut D., Bendtsen F., D'Amico G., Albillos A., Gonzalez A.J., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
11. Villanueva C., Piqueras M., Aracil C., Gomez C., Lopez-Balaguer J.M., Gonzalez B., et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol 45 (2006) 560-567
12. Gonzalez-Abraldes J., Albillos A., Banares R., del Arbol L.R., Moitinho E., Rodriguez C., et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 121 (2001) 382-388
13. Feu F., Ruiz D.A., Banares R., Planas R., and Bosch J. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology 111 (1996) 1291-1299
14. Escorsell A., Bordas J.M., del Arbol L.R., Jaramillo J.L., Planas R., Banares R., et al. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group. J Hepatol 29 (1998) 779-788
15. Escorsell A., Ruiz dA., Planas R., Albillos A., Banares R., Cales P., et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 32 (2000) 471-476
16. Escorsell A., Banares R., Garcia-Pagan J.C., Gilabert R., Moitinho E., Piqueras B., et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35 (2002) 385-392
17. Banares R., Moitinho E., Matilla A., Garcia-Pagan J.C., Lampreave J.L., Piera C., et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 36 (2002) 1367-1373
18. Bosch J., Garcia-Pagan J.C., Berzigotti A., and Abraldes J.G. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 26 (2006) 348-362
19. Garcia-Pagan J., Turnes J., and Bosch J. Measurement of portal pressure. In: Weinstein W.M., Hawkey C.J., and Bosch J. (Eds). Clinical gastroenterology and hepatology (2005), Elsevier, Mosby, Philadelphia 981-986
20. Groszmann R.J., and Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39 (2004) 280-282
21. de Franchis R. Updating consensus in portal hypertension. Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33 (2000) 846-852
22. Sterne J.A., and Davey S.G. Sifting the evidence - what's wrong with significance tests?. BMJ 322 (2001) 226-231
23. Malinchoc M., Kamath P.S., Gordon F.D., Peine C.J., Rank J., and ter Borg P.C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 (2000) 864-871
24. Guyatt G., Haynes B., and Sackett D.L. Analyzing data. In: Haynes B., Sackett D.L., Guyatt G., and Tulliez M. (Eds). Clinical epidemiology (2006), Lippincott Williams and Wilkins, Philadelphia, PA 446-460
25. Altman D.G., and Andersen P.K. Bootstrap investigation of the stability of a Cox regression model. Stat Med 8 (1989) 771-783
26. Steyerberg E.W., Harrell Jr. F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., and Habbema J.D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54 (2001) 774-781
27. Blackstone E.H. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 122 (2001) 430-439
28. Villanueva C., Ortiz J., Sabat M., Gallego A., Torras X., Soriano G., et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 30 (1999) 384-389
29. Banares R., Albillos A., Rincon D., Alonso S., Gonzalez M., Ruiz-del-Arbol L., et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35 (2002) 609-615
30. Braillon A., Cales P., Valla D., Gaudy D., Geoffroy P., and Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 27 (1986) 1204-1209
31. Gluud C., Henriksen J.H., and Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology 8 (1988) 222-227
32. Llach J., Gines P., Arroyo V., Rimola A., Tito L., Badalamenti S., et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 94 (1988) 482-487
33. Moller S., Hillingso J., Christensen E., and Henriksen J.H. Arterial hypoxaemia in cirrhosis: fact or fiction?. Gut 42 (1998) 868-874
34. Vorobioff J., Groszmann R.J., Picabea E., Gamen M., Villavicencio R., Bordato J., et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 111 (1996) 701-709
35. Carrion J.A., Navasa M., Garcia-Retortillo M., Garca-Pagan J.C., Crespo G., Bruguera M., et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 132 (2007) 1746-1756
36. Rincon D., Ripoll C., Lo I.O., Salcedo M., Catalina M.V., Alvarez E., et al. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am J Gastroenterol 101 (2006) 2269-2274